Garen G Bohlin insider trades
Open-market stock purchases and sales by Garen G Bohlin, Unknown at Karyopharm Therapeutics Inc, from SEC Form 4 filings since Mar 25, 2013.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +16%.